Hartwell J L
Cancer Treat Rep. 1976 Aug;60(8):1031-67.
The active compounds which have been isolated from plants and tested in the chemotherapy program of the National Cancer Institute since the inception of the plant program (as part of the Cancer Chemotherapy National Service Center) are listed, classified into types, and discussed in terms of their activity in experimental tumor systems. The tumor systems include the most important ones comprising the regular screen at different times and also the slow-growing tumors, B16 melanoma and Lewis lung carcinoma (new). The structure-antitumor activity relationships bring out the desirability for further investigation of certain types of compounds as possibilities for clinical trial. Notes on the current pharmacologic anc clinical status of certain compounds are also presented.
自植物项目启动(作为癌症化疗国家服务中心的一部分)以来,从植物中分离出来并在美国国立癌症研究所化疗项目中进行测试的活性化合物被列出、分类,并根据它们在实验肿瘤系统中的活性进行了讨论。肿瘤系统包括不同时期常规筛选中最重要的肿瘤系统,以及生长缓慢的肿瘤、B16黑色素瘤和Lewis肺癌(新的)。结构-抗肿瘤活性关系表明有必要进一步研究某些类型的化合物,以作为临床试验的可能性。还介绍了某些化合物目前的药理和临床状况。